BioAtla
BCAB
BCAB
82 hedge funds and large institutions have $51.3M invested in BioAtla in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
47% less capital invested
Capital invested by funds: $96.1M → $51.3M (-$44.7M)
Holders
82
Holding in Top 10
–
Calls
$119K
Puts
$17K
Top Buyers
| 1 | +$471K | |
| 2 | +$386K | |
| 3 | +$254K | |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
+$254K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$177K |
Top Sellers
| 1 | -$1.71M | |
| 2 | -$703K | |
| 3 | -$387K | |
| 4 |
Millennium Management
New York
|
-$327K |
| 5 |
O
OrbiMed
New York
|
-$250K |